Moderna Inc
NASDAQ:MRNA

Watchlist Manager
Moderna Inc Logo
Moderna Inc
NASDAQ:MRNA
Watchlist
Price: 28.24 USD 0.97% Market Closed
Market Cap: 11B USD

Intrinsic Value

The intrinsic value of one MRNA stock under the Base Case scenario is hidden USD. Compared to the current market price of 28.24 USD, Moderna Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

MRNA Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Moderna Inc

Intrinsic Value History
Dive into the past to invest in the future

MRNA looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether MRNA usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about MRNA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is MRNA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Moderna Inc.

Explain Valuation
Compare MRNA to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Moderna’s revenue remains heavily reliant on its COVID-19 vaccine, and diminished global demand for boosters, along with heightened competition from alternative formulations, could significantly erode sales and margins.

Bull Theses

The mRNA platform’s modular nature and rapid development cycle positions Moderna to quickly expand its pipeline beyond COVID-19, enabling potential breakthroughs in vaccines for influenza, RSV, cancer, and rare diseases.

Show More Less
How do you feel about MRNA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Moderna Inc

Current Assets 6.6B
Cash & Short-Term Investments 4.5B
Receivables 1.2B
Other Current Assets 935m
Non-Current Assets 5.5B
Long-Term Investments 2.2B
PP&E 2.9B
Intangibles 99m
Other Non-Current Assets 422m
Current Liabilities 1.7B
Accounts Payable 267m
Accrued Liabilities 1.2B
Other Current Liabilities 219m
Non-Current Liabilities 1.1B
Long-Term Debt 26m
Other Non-Current Liabilities 1.1B
Efficiency

Free Cash Flow Analysis
Moderna Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Moderna Inc

Revenue
2.2B USD
Cost of Revenue
-815m USD
Gross Profit
1.4B USD
Operating Expenses
-4.5B USD
Operating Income
-3.1B USD
Other Expenses
7m USD
Net Income
-3.1B USD
Fundamental Scores

MRNA Profitability Score
Profitability Due Diligence

Moderna Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Declining Gross Margin
Declining Net Margin
hidden
Profitability
Score

Moderna Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

MRNA Solvency Score
Solvency Due Diligence

Moderna Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Negative Net Debt
Low D/E
Short-Term Solvency
hidden
Solvency
Score

Moderna Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MRNA Price Targets Summary
Moderna Inc

Wall Street analysts forecast MRNA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRNA is 38.07 USD with a low forecast of 17.17 USD and a high forecast of 141.75 USD.

Lowest
Price Target
17.17 USD
39% Downside
Average
Price Target
38.07 USD
35% Upside
Highest
Price Target
141.75 USD
402% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Moderna Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MRNA is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

MRNA Insider Trading
Buy and sell transactions by insiders

MRNA News

Other Videos
What is the Intrinsic Value of one MRNA stock?

The intrinsic value of one MRNA stock under the Base Case scenario is hidden USD.

Is MRNA stock undervalued or overvalued?

Compared to the current market price of 28.24 USD, Moderna Inc is hidden .

Back to Top